Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET-Reference-Cited by-同舟云学术

Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET

Published:2013-04-11 Issue:6 Volume:54 Page:936-943
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Janjigian Yelena Y.,Viola-Villegas Nerissa,Holland Jason P.,Divilov Vadim,Carlin Sean D.,Gomes-DaGama Erica M.,Chiosis Gabriela,Carbonetti Gregory,de Stanchina Elisa,Lewis Jason S.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference37 articles.

1. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

2. Human Epidermal Growth Factor Receptor 2 Testing in Gastroesophageal Cancer: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization

3. Assessment of a HER2 scoring system for gastric cancer: results from a validation study

4. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

5. Untangling the ErbB signalling network

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular SPECT/CT Profiling of Claudin18.2 Expression In Vivo: Implication for Patients with Gastric Cancer;Molecular Pharmaceutics;2024-06-06

2. Curcumin potentiates the ErbB receptors inhibitor Afatinib for enhanced antitumor activity in malignant mesothelioma;International Journal of Food Sciences and Nutrition;2023-09-03

3. Challenges and future of HER2-positive gastric cancer therapy;Frontiers in Oncology;2023-01-30

4. Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma;Annals of Oncology;2022-11

5. HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer;Molecular Imaging and Biology;2022-08-12